Your browser doesn't support javascript.
loading
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Liao, Limin; Liu, Qinggang; Cong, Huiling; Xu, Zhihui; Li, Enhui; Weng, Zhiliang; Jiang, Haihong; Liu, Ben; Huang, Xiao; Xia, Shujie; Wen, Wei; Wu, Juan; Shi, Guowei; Wang, Yang; Li, Peijun; Yu, Yang; Fang, Zujun; Zheng, Jie; Tian, Ye; Shang, Donghao; Li, Hanzhong; Huang, Zhongming; Zhou, Liqun; Xiao, Yunxiang; Zhang, Yaoguang; Wang, Jianlong; Zhang, Xiaodong; Zhang, Peng; Wang, Dongwen; Zhang, Xuhui; Xie, Keji; Wang, Bin; Ma, Lulin; Tian, Xiaojun; Chen, Lijun; Dong, Jinkai.
Afiliação
  • Liao L; Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
  • Liu Q; Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Cong H; University of Health and Rehabilitation Sciences, Qingdao, China.
  • Xu Z; Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
  • Li E; Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Weng Z; University of Health and Rehabilitation Sciences, Qingdao, China.
  • Jiang H; Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
  • Liu B; Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Huang X; Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Xia S; Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Wen W; Department of Urology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wu J; Department of Urology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Shi G; Department of Urology, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Wang Y; Department of Urology, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Li P; Department of Urology, Shanghai First People's Hospital, Shanghai, China.
  • Yu Y; Department of Urology, Shanghai First People's Hospital, Shanghai, China.
  • Fang Z; Department of Urology, China Rehabilitation Research Center, School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
  • Zheng J; Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Tian Y; Department of Urology, Shanghai Fifth People's Hospital, Shanghai, China.
  • Shang D; Department of Urology, Shanghai Fifth People's Hospital, Shanghai, China.
  • Li H; Department of Urology, Ningxia Medical University General Hospital, Xining, China.
  • Huang Z; Department of Urology, Ningxia Medical University General Hospital, Xining, China.
  • Zhou L; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Xiao Y; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhang Y; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Wang J; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhang X; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Zhang P; Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang D; Department of Urology, Peking University First Hospital, Beijing, China.
  • Zhang X; Department of Urology, Peking University First Hospital, Beijing, China.
  • Xie K; Department of Urology, Beijing Hospital, Beijing, China.
  • Wang B; Department of Urology, Beijing Hospital, Beijing, China.
  • Ma L; Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Tian X; Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Chen L; Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Dong J; Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Front Pharmacol ; 13: 840695, 2022.
Article em En | MEDLINE | ID: mdl-35250586
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça